Oncotarget | NF-κB Over-Activation Portends Improved Outcomes in HPV+ HNSCC
May 25, 2022
“Since clinicians are exploring therapeutic deintensification for HPV+ HNSCC, identifying patients with good or poor prognosis using the NF-κB Activity Classifier may be useful to guide therapeutic decisions.” Listen to… read more